Market Overview

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Outlook to 2023: Rise in the Miniaturization of Nucleic Acid-based Diagnostics - ResearchAndMarkets.com

Share:

The "Global
Isothermal Nucleic Acid Amplification Technology (INAAT) Market -
Segmented by Technology, Application, and Geography - Growth, Trends,
and Forecast (2018 - 2023)"
report has been added to ResearchAndMarkets.com's
offering.

The global isothermal nucleic acid amplification technology (INAAT)
market is expected to register a CAGR of 10.5%, during the forecast
period, (2018-2023).

Rise in the Miniaturization of Nucleic Acid-based Diagnostics

Miniaturization of biochemical reactions leads to major advantages,
where a lower amount of valuable clinical sample and reagents is just
one: approximately 1/1000 of the volume used in conventional lab setups
has been shown to obtain a similar result. A smaller heat capacity
allows for rapid changes in temperature beneficial for the PCR time, as
well as a higher parallelism of multiple genetic samples.

The benefit of isothermal amplification methods compared to PCR is the
constant temperature of amplification. This will result in a high
potential for a simple integration in point-of-care devices and a
reduction of complexity.

With increasing demand of low cost and effective solutions for diagnosis
of diseases and increasing demand for point of care applications, these
devices are going to witness growth in the future.

Also in case of laboratories the sample size required is very small
which also helps in reducing the amount of reagents required. Also, the
upsurge in the molecular diagnostics market, increasing incidences of
chronic diseases and aging population, and increase in the adoption of
INAAT over PCR are driving the market growth.

Key Highlights

  • Stringent Regulatory Framework
  • North America to Dominate the Market

Notable Developments

  • Alere Inc., a global leader in rapid diagnostic tests, announced that
    the U.S. Food and Drug Administration (FDA) has granted CLIA waiver
    for the Alere i Strep A test.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

  • Alere
  • Becton, Dickinson & Company
  • Biomeriux
  • Hologica
  • Lucigen
  • Quidel Corporation
  • New England Biolabs
  • Nugen
  • Qiagen
  • Ustar Biotechnologies

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/x4ghkn/global_isothermal?w=4

View Comments and Join the Discussion!